WASHINGTON, D.C – Today, U.S. Senator Tammy Baldwin (D-WI) applauded the U.S. Department of Health and Human Services’ (HHS) announcement that 15 additional drugs covered under Medicare have been selected for price negotiations, including drugs to treat a variety of conditions, such as cancer, type 2 diabetes, and asthma. The Baldwin-backed Inflation Reduction Act empowered Medicare...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
